148 related articles for article (PubMed ID: 27020572)
21. Feline lentiviruses demonstrate differences in receptor repertoire and envelope structural elements.
Smirnova N; Troyer JL; Schissler J; Terwee J; Poss M; VandeWoude S
Virology; 2005 Nov; 342(1):60-76. PubMed ID: 16120451
[TBL] [Abstract][Full Text] [Related]
22. Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity.
Duda A; Stange A; Lüftenegger D; Stanke N; Westphal D; Pietschmann T; Eastman SW; Linial ML; Rethwilm A; Lindemann D
J Virol; 2004 Dec; 78(24):13865-70. PubMed ID: 15564494
[TBL] [Abstract][Full Text] [Related]
23. Extensive sequence variation of feline immunodeficiency virus env genes in isolates from naturally infected cats.
Greene WK; Meers J; del Fierro G; Carnegie PR; Robinson WF
Arch Virol; 1993; 133(1-2):51-62. PubMed ID: 8240017
[TBL] [Abstract][Full Text] [Related]
24. Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication.
de Parseval A; Ngo S; Sun P; Elder JH
J Virol; 2004 Sep; 78(17):9132-43. PubMed ID: 15308709
[TBL] [Abstract][Full Text] [Related]
25. Dissection of seroreactivity against the tryptophan-rich motif of the feline immunodeficiency virus transmembrane glycoprotein.
Freer G; Giannecchini S; Tissot A; Bachmann MF; Rovero P; Serres PF; Bendinelli M
Virology; 2004 May; 322(2):360-9. PubMed ID: 15110533
[TBL] [Abstract][Full Text] [Related]
26. Biophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix protein.
Serrière J; Robert X; Perez M; Gouet P; Guillon C
Retrovirology; 2013 Jun; 10():64. PubMed ID: 23800358
[TBL] [Abstract][Full Text] [Related]
27. Small variations in the length of the cytoplasmic domain of the simian immunodeficiency virus transmembrane protein drastically affect envelope incorporation and virus entry.
Manrique JM; Celma CC; Affranchino JL; Hunter E; González SA
AIDS Res Hum Retroviruses; 2001 Nov; 17(17):1615-24. PubMed ID: 11779349
[TBL] [Abstract][Full Text] [Related]
28. Antiviral activity of membrane fusion inhibitors that target gp40 of the feline immunodeficiency virus envelope protein.
Mizukoshi F; Baba K; Goto Y; Setoguchi A; Fujino Y; Ohno K; Oishi S; Kodera Y; Fujii N; Tsujimoto H
Vet Microbiol; 2009 Apr; 136(1-2):155-9. PubMed ID: 19036536
[TBL] [Abstract][Full Text] [Related]
29. Most potential linear B cell epitopes of Env glycoproteins of feline immunodeficiency virus are immunogenically silent in infected cats.
Massi C; Lombardi S; Indino E; Matteucci D; La Rosa C; Esposito F; Garzelli C; Bendinelli M
AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1121-9. PubMed ID: 9282817
[TBL] [Abstract][Full Text] [Related]
30. The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus.
Willett BJ; Adema K; Heveker N; Brelot A; Picard L; Alizon M; Turner JD; Hoxie JA; Peiper S; Neil JC; Hosie MJ
J Virol; 1998 Aug; 72(8):6475-81. PubMed ID: 9658090
[TBL] [Abstract][Full Text] [Related]
31. Analysis and function of prototype foamy virus envelope N glycosylation.
Lüftenegger D; Picard-Maureau M; Stanke N; Rethwilm A; Lindemann D
J Virol; 2005 Jun; 79(12):7664-72. PubMed ID: 15919919
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of feline immunodeficiency virus envelope glycoprotein-mediated fusion.
Garg H; Fuller FJ; Tompkins WA
Virology; 2004 Apr; 321(2):274-86. PubMed ID: 15051387
[TBL] [Abstract][Full Text] [Related]
33. A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropism.
Vahlenkamp TW; Verschoor EJ; Schuurman NN; van Vliet AL; Horzinek MC; Egberink HF; de Ronde A
J Virol; 1997 Sep; 71(9):7132-5. PubMed ID: 9261450
[TBL] [Abstract][Full Text] [Related]
34. Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.
Lavillette D; Ruggieri A; Boson B; Maurice M; Cosset FL
J Virol; 2002 Oct; 76(19):9673-85. PubMed ID: 12208946
[TBL] [Abstract][Full Text] [Related]
35. Glycan moiety modifications of feline alpha1-acid glycoprotein in retrovirus (FIV, FeLV) affected cats.
Pocacqua V; Provasi E; Paltrinieri S; Gelain E; Comunian C; Ceciliani F
Vet Immunol Immunopathol; 2005 Aug; 107(1-2):17-26. PubMed ID: 15982476
[TBL] [Abstract][Full Text] [Related]
36. Ancestral Mutations Acquired in Refrex-1, a Restriction Factor against Feline Retroviruses, during its Cooption and Domestication.
Ito J; Baba T; Kawasaki J; Nishigaki K
J Virol; 2016 Feb; 90(3):1470-85. PubMed ID: 26581999
[TBL] [Abstract][Full Text] [Related]
37. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein.
Lavillette D; Boson B; Russell SJ; Cosset FL
J Virol; 2001 Apr; 75(8):3685-95. PubMed ID: 11264358
[TBL] [Abstract][Full Text] [Related]
38. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O
AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908
[TBL] [Abstract][Full Text] [Related]
39. Post-translational processing of the feline immunodeficiency virus envelope precursor protein.
Verschoor EJ; Hulskotte EG; Ederveen J; Koolen MJ; Horzinek MC; Rottier PJ
Virology; 1993 Mar; 193(1):433-8. PubMed ID: 8382405
[TBL] [Abstract][Full Text] [Related]
40. Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein.
Johnston ER; Albritton LM; Radke K
J Virol; 2002 Nov; 76(21):10861-72. PubMed ID: 12368329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
